

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.97292894 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.89231351 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.89231351 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.89231351 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.89231351 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.89231351 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.89231351 |
| 8 | cellular extravasation (GO:0045123) | 5.45587537 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.35813118 |
| 10 | respiratory burst (GO:0045730) | 5.30928309 |
| 11 | detection of bacterium (GO:0016045) | 5.26556590 |
| 12 | response to peptidoglycan (GO:0032494) | 5.16554541 |
| 13 | neutrophil mediated immunity (GO:0002446) | 5.03428582 |
| 14 | leukocyte aggregation (GO:0070486) | 4.95182810 |
| 15 | positive regulation of mast cell activation (GO:0033005) | 4.89059596 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.80872260 |
| 17 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.70714122 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.68148137 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.60968330 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.52669229 |
| 21 | regulation of mast cell degranulation (GO:0043304) | 4.52276525 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.48222849 |
| 23 | neutrophil activation (GO:0042119) | 4.46635267 |
| 24 | regulation of mast cell activation (GO:0033003) | 4.39054546 |
| 25 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.38873658 |
| 26 | response to host immune response (GO:0052572) | 4.37293799 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.37293799 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.37228188 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.36827950 |
| 30 | positive regulation of mast cell degranulation (GO:0043306) | 4.32332209 |
| 31 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.32332209 |
| 32 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.28076741 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.25415025 |
| 34 | granulocyte activation (GO:0036230) | 4.22421179 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15361746 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13355662 |
| 37 | response to fungus (GO:0009620) | 4.11890899 |
| 38 | detection of biotic stimulus (GO:0009595) | 4.11855122 |
| 39 | response to host (GO:0075136) | 4.06583155 |
| 40 | response to host defenses (GO:0052200) | 4.06583155 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.06583155 |
| 42 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.01343067 |
| 43 | response to interleukin-15 (GO:0070672) | 4.00275900 |
| 44 | defense response to fungus (GO:0050832) | 3.95989634 |
| 45 | regulation of leukocyte degranulation (GO:0043300) | 3.95901846 |
| 46 | negative regulation of phagocytosis (GO:0050765) | 3.91920517 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.91798700 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.91798700 |
| 49 | negative regulation of granulocyte differentiation (GO:0030853) | 3.90867647 |
| 50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89943610 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.87337903 |
| 52 | microglial cell activation (GO:0001774) | 3.86318930 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.86208457 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.81699241 |
| 55 | myeloid leukocyte mediated immunity (GO:0002444) | 3.72662393 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.71278146 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.69947070 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.68620945 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.67481575 |
| 60 | macrophage differentiation (GO:0030225) | 3.65459362 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64302178 |
| 62 | neutrophil chemotaxis (GO:0030593) | 3.62629638 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.60237496 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 3.57457601 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.54196329 |
| 66 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.52711624 |
| 67 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52711624 |
| 68 | neutrophil migration (GO:1990266) | 3.52067652 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50469403 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47028929 |
| 71 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46127164 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.44349309 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.44348980 |
| 74 | cellular response to type I interferon (GO:0071357) | 3.44149624 |
| 75 | type I interferon signaling pathway (GO:0060337) | 3.44149624 |
| 76 | response to type I interferon (GO:0034340) | 3.41568069 |
| 77 | B cell mediated immunity (GO:0019724) | 3.39924189 |
| 78 | positive regulation of leukocyte degranulation (GO:0043302) | 3.39392611 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.38148312 |
| 80 | negative regulation of mast cell activation (GO:0033004) | 3.38145310 |
| 81 | macrophage activation (GO:0042116) | 3.36102370 |
| 82 | leukotriene metabolic process (GO:0006691) | 3.36004628 |
| 83 | leukocyte mediated cytotoxicity (GO:0001909) | 3.34336371 |
| 84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34093189 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32542415 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.29791254 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 3.26946131 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.26590836 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26590836 |
| 90 | leukocyte cell-cell adhesion (GO:0007159) | 3.23429425 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 3.22176594 |
| 92 | positive regulation of lamellipodium assembly (GO:0010592) | 3.20464842 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20343499 |
| 94 | cellular response to zinc ion (GO:0071294) | 3.19708518 |
| 95 | reactive oxygen species biosynthetic process (GO:1903409) | 3.19012920 |
| 96 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.18615660 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16915627 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16458225 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16371737 |
| 100 | lipoxygenase pathway (GO:0019372) | 3.15782415 |
| 101 | detection of other organism (GO:0098543) | 3.13264488 |
| 102 | pinocytosis (GO:0006907) | 3.13202593 |
| 103 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.11047856 |
| 104 | regulation of integrin activation (GO:0033623) | 3.09694980 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.06776814 |
| 106 | superoxide anion generation (GO:0042554) | 3.06188346 |
| 107 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06105704 |
| 108 | granulocyte chemotaxis (GO:0071621) | 3.05596917 |
| 109 | positive regulation of interferon-beta production (GO:0032728) | 3.05425888 |
| 110 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05389748 |
| 111 | dendritic cell migration (GO:0036336) | 3.01805788 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.00176681 |
| 113 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99980170 |
| 114 | granulocyte migration (GO:0097530) | 2.98759029 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.98417909 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.98342089 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 2.97632134 |
| 118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.96929338 |
| 119 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95846986 |
| 120 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.95593051 |
| 121 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.95593051 |
| 122 | negative regulation of type 2 immune response (GO:0002829) | 2.95577319 |
| 123 | actin nucleation (GO:0045010) | 2.95307855 |
| 124 | regulation of phagocytosis (GO:0050764) | 2.93970423 |
| 125 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93468377 |
| 126 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93468377 |
| 127 | leukocyte degranulation (GO:0043299) | 2.91818476 |
| 128 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91433902 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.90528633 |
| 130 | positive regulation of lamellipodium organization (GO:1902745) | 2.89011473 |
| 131 | activated T cell proliferation (GO:0050798) | 2.88777983 |
| 132 | * regulation of B cell differentiation (GO:0045577) | 2.85019158 |
| 133 | * B cell receptor signaling pathway (GO:0050853) | 2.84652574 |
| 134 | mannose metabolic process (GO:0006013) | 2.83993763 |
| 135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.77481470 |
| 136 | leukotriene biosynthetic process (GO:0019370) | 2.75884610 |
| 137 | germinal center formation (GO:0002467) | 2.75783857 |
| 138 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73341117 |
| 139 | defense response to protozoan (GO:0042832) | 2.72887013 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72805588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.46993635 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.13539743 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22831769 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91429742 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83127852 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.79374961 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.69263697 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37537352 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.13802217 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.04590182 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02652797 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91324421 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87868389 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83394434 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.79907758 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.66241645 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62689301 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60300837 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54094426 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49274362 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42756323 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39622717 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23140172 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19633747 |
| 25 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.10010241 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.08892991 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05769489 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03096157 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.98490378 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93818024 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92261274 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.92186200 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87306344 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86365598 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77566263 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75597875 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74769558 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74748859 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72200251 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70365077 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.68981217 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66512175 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62246040 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61937467 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61870032 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60742789 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58670297 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58116481 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56595958 |
| 50 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54808975 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53212656 |
| 52 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51783192 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47985981 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45690920 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42385916 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41997500 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36213496 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35981488 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33488463 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32093101 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31291914 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30516855 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29758117 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28939014 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26085944 |
| 66 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25036608 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24758125 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24068247 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23840215 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23452252 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22607037 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22351741 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20588263 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18152045 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.17896599 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17357174 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17212414 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16970528 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16627254 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16206107 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15760857 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13848248 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11989023 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11679635 |
| 85 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08917710 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06412923 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03403764 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97965898 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96698765 |
| 90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94175894 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92485593 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92141532 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91441726 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89690629 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89385657 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88168523 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87957777 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.84433120 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84004768 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83370381 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83100399 |
| 102 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82565073 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81778483 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81701286 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79209090 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78448711 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78219769 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74452595 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73690410 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.69767828 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 0.69766774 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68924903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.03366609 |
| 2 | MP0003303_peritoneal_inflammation | 3.93935388 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.78510762 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.41857248 |
| 5 | MP0002419_abnormal_innate_immunity | 3.25525331 |
| 6 | MP0009278_abnormal_bone_marrow | 3.14403465 |
| 7 | MP0009785_altered_susceptibility_to | 2.85825129 |
| 8 | MP0005025_abnormal_response_to | 2.68652790 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.65404950 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.65099565 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.61827949 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.56242298 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.52222554 |
| 14 | MP0006082_CNS_inflammation | 2.45944891 |
| 15 | MP0000685_abnormal_immune_system | 2.45025119 |
| 16 | MP0001800_abnormal_humoral_immune | 2.44332274 |
| 17 | MP0001790_abnormal_immune_system | 2.35504486 |
| 18 | MP0005387_immune_system_phenotype | 2.35504486 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.34943537 |
| 20 | MP0002723_abnormal_immune_serum | 2.24938347 |
| 21 | MP0001819_abnormal_immune_cell | 2.24491733 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.24327734 |
| 23 | MP0002405_respiratory_system_inflammati | 2.19662272 |
| 24 | MP0001853_heart_inflammation | 2.19592292 |
| 25 | MP0001545_abnormal_hematopoietic_system | 2.16681525 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.16681525 |
| 27 | MP0003724_increased_susceptibility_to | 2.16271281 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.02527429 |
| 29 | MP0005671_abnormal_response_to | 1.99942717 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.98243080 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.96153852 |
| 32 | MP0000343_altered_response_to | 1.93584982 |
| 33 | MP0003075_altered_response_to | 1.88214477 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.85843793 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.82008037 |
| 36 | MP0004510_myositis | 1.81277235 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.75037405 |
| 38 | MP0002398_abnormal_bone_marrow | 1.73996515 |
| 39 | MP0000716_abnormal_immune_system | 1.73739955 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.70805326 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.67777548 |
| 42 | MP0009840_abnormal_foam_cell | 1.61404727 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.52695012 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.48874292 |
| 45 | MP0005451_abnormal_body_composition | 1.48277891 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.48201649 |
| 47 | MP0002429_abnormal_blood_cell | 1.48114008 |
| 48 | MP0002722_abnormal_immune_system | 1.46024549 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.44924152 |
| 50 | MP0008469_abnormal_protein_level | 1.43960611 |
| 51 | MP0000858_altered_metastatic_potential | 1.42274969 |
| 52 | MP0004947_skin_inflammation | 1.39795062 |
| 53 | MP0003448_altered_tumor_morphology | 1.39477405 |
| 54 | MP0001851_eye_inflammation | 1.38397684 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.37538379 |
| 56 | MP0004381_abnormal_hair_follicle | 1.35670129 |
| 57 | MP0003828_pulmonary_edema | 1.34224514 |
| 58 | MP0009764_decreased_sensitivity_to | 1.32484512 |
| 59 | MP0001873_stomach_inflammation | 1.28481617 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.26879944 |
| 61 | MP0002933_joint_inflammation | 1.26523744 |
| 62 | MP0000490_abnormal_crypts_of | 1.22254036 |
| 63 | MP0002006_tumorigenesis | 1.18440526 |
| 64 | MP0010307_abnormal_tumor_latency | 1.16171212 |
| 65 | MP0005310_abnormal_salivary_gland | 1.15791509 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.14956959 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.12267671 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.12043775 |
| 69 | MP0005166_decreased_susceptibility_to | 1.09938172 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.07010868 |
| 71 | MP0003690_abnormal_glial_cell | 1.06764605 |
| 72 | MP0004883_abnormal_blood_vessel | 1.02004046 |
| 73 | MP0008057_abnormal_DNA_replication | 1.00086944 |
| 74 | MP0005390_skeleton_phenotype | 0.97880129 |
| 75 | MP0000371_diluted_coat_color | 0.92654175 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.91650041 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.90893395 |
| 78 | MP0008004_abnormal_stomach_pH | 0.90576374 |
| 79 | MP0005164_abnormal_response_to | 0.89986584 |
| 80 | MP0000604_amyloidosis | 0.87356285 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.86410175 |
| 82 | MP0005023_abnormal_wound_healing | 0.86279187 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.84233472 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.83271286 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.83213026 |
| 86 | MP0000249_abnormal_blood_vessel | 0.82545212 |
| 87 | MP0003279_aneurysm | 0.82299362 |
| 88 | MP0009763_increased_sensitivity_to | 0.81351884 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.78907587 |
| 90 | MP0003045_fibrosis | 0.75175991 |
| 91 | MP0002132_abnormal_respiratory_system | 0.72924351 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.72446224 |
| 93 | MP0003866_abnormal_defecation | 0.69191651 |
| 94 | MP0001663_abnormal_digestive_system | 0.69092031 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.67505924 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.66448929 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.66155237 |
| 98 | MP0003878_abnormal_ear_physiology | 0.66080486 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.66080486 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.63996655 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.63021743 |
| 102 | MP0008874_decreased_physiological_sensi | 0.62768339 |
| 103 | MP0003795_abnormal_bone_structure | 0.61653555 |
| 104 | MP0004130_abnormal_muscle_cell | 0.61524692 |
| 105 | MP0004858_abnormal_nervous_system | 0.59968340 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.58496985 |
| 107 | MP0005083_abnormal_biliary_tract | 0.57633168 |
| 108 | MP0008873_increased_physiological_sensi | 0.56964553 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55968543 |
| 110 | MP0002928_abnormal_bile_duct | 0.55816961 |
| 111 | MP0000609_abnormal_liver_physiology | 0.55691314 |
| 112 | MP0008260_abnormal_autophagy | 0.54360791 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.54324341 |
| 114 | MP0002133_abnormal_respiratory_system | 0.53525178 |
| 115 | MP0005388_respiratory_system_phenotype | 0.53525178 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.53350244 |
| 117 | MP0001915_intracranial_hemorrhage | 0.53003999 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.52423230 |
| 119 | MP0000598_abnormal_liver_morphology | 0.52246540 |
| 120 | MP0001958_emphysema | 0.52009009 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.50527817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.82486627 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.89163754 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.66651492 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.19455092 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.14334746 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.79053643 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.58922795 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.51409597 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.43429505 |
| 10 | Obstructive lung disease (HP:0006536) | 4.43429505 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.27697647 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.26531047 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.23889295 |
| 14 | Myositis (HP:0100614) | 4.20119972 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 4.16062937 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.12089179 |
| 17 | Recurrent skin infections (HP:0001581) | 4.10353585 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.88765853 |
| 19 | Pustule (HP:0200039) | 3.88312558 |
| 20 | Gingivitis (HP:0000230) | 3.86503008 |
| 21 | Encephalitis (HP:0002383) | 3.77293272 |
| 22 | Glomerulonephritis (HP:0000099) | 3.64389904 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.61755105 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.57822986 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.57822986 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53689141 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.51478701 |
| 28 | Hypochromic anemia (HP:0001931) | 3.48861206 |
| 29 | Cellulitis (HP:0100658) | 3.44646968 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.36667083 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.36667083 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.36667083 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.34232096 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.34232096 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.34232096 |
| 36 | Episodic fever (HP:0001954) | 3.28956596 |
| 37 | IgM deficiency (HP:0002850) | 3.26800075 |
| 38 | Orchitis (HP:0100796) | 3.23703051 |
| 39 | Stomatitis (HP:0010280) | 3.14992697 |
| 40 | Urticaria (HP:0001025) | 3.09346729 |
| 41 | Meningitis (HP:0001287) | 3.09094379 |
| 42 | Periodontitis (HP:0000704) | 3.00052685 |
| 43 | Amyloidosis (HP:0011034) | 3.00023087 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.91881202 |
| 45 | Peritonitis (HP:0002586) | 2.91164912 |
| 46 | Colitis (HP:0002583) | 2.90420747 |
| 47 | Disinhibition (HP:0000734) | 2.89902504 |
| 48 | Recurrent viral infections (HP:0004429) | 2.88118892 |
| 49 | Agnosia (HP:0010524) | 2.87759316 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.86218309 |
| 51 | Hematochezia (HP:0002573) | 2.83871736 |
| 52 | Anorexia (HP:0002039) | 2.82190761 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.80258423 |
| 54 | T lymphocytopenia (HP:0005403) | 2.77582061 |
| 55 | Pulmonary embolism (HP:0002204) | 2.72266602 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.71232577 |
| 57 | Axonal loss (HP:0003447) | 2.70904115 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.67822319 |
| 59 | Loss of speech (HP:0002371) | 2.66407062 |
| 60 | Petechiae (HP:0000967) | 2.65561587 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.62876374 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.62654003 |
| 63 | Microcytic anemia (HP:0001935) | 2.57022907 |
| 64 | Abnormality of complement system (HP:0005339) | 2.55275679 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.54097606 |
| 66 | Epistaxis (HP:0000421) | 2.52356601 |
| 67 | Vasculitis (HP:0002633) | 2.52054447 |
| 68 | Retrobulbar optic neuritis (HP:0100654) | 2.49381645 |
| 69 | Optic neuritis (HP:0100653) | 2.49381645 |
| 70 | Increased IgM level (HP:0003496) | 2.48768197 |
| 71 | Abnormality of T cells (HP:0002843) | 2.45800710 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45502244 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45502244 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 2.42856182 |
| 75 | Osteomyelitis (HP:0002754) | 2.41595452 |
| 76 | Thoracic kyphosis (HP:0002942) | 2.40171342 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.39205894 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37405718 |
| 79 | Granulocytopenia (HP:0001913) | 2.35771660 |
| 80 | Complement deficiency (HP:0004431) | 2.35350312 |
| 81 | Nephritis (HP:0000123) | 2.34717972 |
| 82 | Chronic otitis media (HP:0000389) | 2.34529387 |
| 83 | Gangrene (HP:0100758) | 2.33964917 |
| 84 | Leukocytosis (HP:0001974) | 2.30274028 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29828956 |
| 86 | Abnormal platelet function (HP:0011869) | 2.27666723 |
| 87 | Impaired platelet aggregation (HP:0003540) | 2.27666723 |
| 88 | Purpura (HP:0000979) | 2.26981545 |
| 89 | Thrombocytosis (HP:0001894) | 2.24859760 |
| 90 | Prostate neoplasm (HP:0100787) | 2.24181010 |
| 91 | Lymphopenia (HP:0001888) | 2.22555760 |
| 92 | Abnormality of the peritoneum (HP:0002585) | 2.22134564 |
| 93 | Spondylolisthesis (HP:0003302) | 2.19868290 |
| 94 | Increased serum ferritin (HP:0003281) | 2.19819379 |
| 95 | Gingival bleeding (HP:0000225) | 2.19503622 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.18141238 |
| 97 | Recurrent lower respiratory tract infections (HP:0002783) | 2.13368469 |
| 98 | Abnormality of the endocardium (HP:0004306) | 2.12801622 |
| 99 | Myocardial infarction (HP:0001658) | 2.12777364 |
| 100 | Premature loss of primary teeth (HP:0006323) | 2.12203542 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.11332577 |
| 102 | Glomerulopathy (HP:0100820) | 2.11242407 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.08442356 |
| 104 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07606549 |
| 105 | Acne (HP:0001061) | 2.07195885 |
| 106 | Abnormality of the pericardium (HP:0001697) | 2.07159125 |
| 107 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07074202 |
| 108 | Abnormal platelet volume (HP:0011876) | 2.06562783 |
| 109 | Arterial thrombosis (HP:0004420) | 2.06202441 |
| 110 | Albinism (HP:0001022) | 2.04653707 |
| 111 | Vertigo (HP:0002321) | 2.04620505 |
| 112 | Basal ganglia calcification (HP:0002135) | 2.03653038 |
| 113 | Abnormality of the prostate (HP:0008775) | 2.00196145 |
| 114 | Progressive neurologic deterioration (HP:0002344) | 2.00051588 |
| 115 | Chest pain (HP:0100749) | 1.99671690 |
| 116 | Keratitis (HP:0000491) | 1.99309007 |
| 117 | Sepsis (HP:0100806) | 1.99190632 |
| 118 | Abnormality of the thoracic spine (HP:0100711) | 1.98930302 |
| 119 | Pulmonary infiltrates (HP:0002113) | 1.96209609 |
| 120 | Skin ulcer (HP:0200042) | 1.96081307 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 1.95877604 |
| 122 | Abnormality of the lumbar spine (HP:0100712) | 1.95840666 |
| 123 | Polyneuropathy (HP:0001271) | 1.92406039 |
| 124 | Cheilitis (HP:0100825) | 1.91016887 |
| 125 | Slow saccadic eye movements (HP:0000514) | 1.90153649 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89920748 |
| 127 | J-shaped sella turcica (HP:0002680) | 1.89867627 |
| 128 | Upper motor neuron abnormality (HP:0002127) | 1.88636993 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.88246640 |
| 130 | Pathologic fracture (HP:0002756) | 1.86642493 |
| 131 | Polycythemia (HP:0001901) | 1.85900315 |
| 132 | Hemoptysis (HP:0002105) | 1.85291150 |
| 133 | Increased IgE level (HP:0003212) | 1.83764680 |
| 134 | Joint hemorrhage (HP:0005261) | 1.81183868 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80728463 |
| 136 | Hypermelanotic macule (HP:0001034) | 1.80095149 |
| 137 | Eosinophilia (HP:0001880) | 1.79475807 |
| 138 | Keratoconjunctivitis sicca (HP:0001097) | 1.79354685 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.77959548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.65194365 |
| 2 | IRAK4 | 3.64781816 |
| 3 | MAP4K1 | 3.44701107 |
| 4 | ERN1 | 3.13563905 |
| 5 | RIPK4 | 2.81630851 |
| 6 | CSK | 2.65285419 |
| 7 | TYK2 | 2.52611902 |
| 8 | FGR | 2.41186505 |
| 9 | KIT | 2.34951178 |
| 10 | TGFBR2 | 2.33028114 |
| 11 | MAP2K3 | 2.23594750 |
| 12 | BTK | 2.23401833 |
| 13 | STK10 | 2.16829902 |
| 14 | TBK1 | 2.11284593 |
| 15 | MATK | 2.10600643 |
| 16 | PRPF4B | 2.07351992 |
| 17 | FES | 2.06959357 |
| 18 | CSF1R | 2.04460071 |
| 19 | CLK1 | 1.99350411 |
| 20 | EPHB1 | 1.97523756 |
| 21 | TEC | 1.88941192 |
| 22 | IRAK3 | 1.87105739 |
| 23 | ZAP70 | 1.77222131 |
| 24 | MAP3K6 | 1.74931522 |
| 25 | HCK | 1.63056188 |
| 26 | TRPM7 | 1.56249440 |
| 27 | MAP3K11 | 1.49863024 |
| 28 | TAOK3 | 1.48104933 |
| 29 | TRIB3 | 1.46151677 |
| 30 | MAP3K14 | 1.42954333 |
| 31 | SIK3 | 1.42361741 |
| 32 | SYK | 1.37968285 |
| 33 | IKBKB | 1.36954582 |
| 34 | LYN | 1.31931693 |
| 35 | GRK6 | 1.31020538 |
| 36 | MAP3K1 | 1.30522042 |
| 37 | KSR2 | 1.27777800 |
| 38 | PAK4 | 1.20213394 |
| 39 | PIM2 | 1.19195049 |
| 40 | PIM1 | 1.18428065 |
| 41 | CAMK1D | 1.10019992 |
| 42 | TXK | 1.07719512 |
| 43 | LRRK2 | 1.07470449 |
| 44 | JAK3 | 1.06392633 |
| 45 | JAK1 | 1.06370992 |
| 46 | LCK | 1.06159753 |
| 47 | MARK2 | 1.05857940 |
| 48 | IKBKE | 1.05387465 |
| 49 | ITK | 1.03905099 |
| 50 | MAPK15 | 1.03714359 |
| 51 | PRKD2 | 1.02453574 |
| 52 | NEK9 | 0.98022283 |
| 53 | IRAK1 | 0.97685300 |
| 54 | PKN2 | 0.95128927 |
| 55 | CDK19 | 0.94085167 |
| 56 | RIPK1 | 0.92416892 |
| 57 | JAK2 | 0.90704123 |
| 58 | IRAK2 | 0.90504996 |
| 59 | RPS6KA6 | 0.90222348 |
| 60 | RPS6KA4 | 0.85366043 |
| 61 | RPS6KC1 | 0.85245923 |
| 62 | RPS6KL1 | 0.85245923 |
| 63 | MAP3K3 | 0.79107787 |
| 64 | DAPK1 | 0.75432155 |
| 65 | CDK6 | 0.74936203 |
| 66 | PTK6 | 0.73930545 |
| 67 | TTN | 0.72375755 |
| 68 | YES1 | 0.71078617 |
| 69 | GRK7 | 0.70974895 |
| 70 | TESK2 | 0.70114317 |
| 71 | MARK3 | 0.70061093 |
| 72 | MAP2K4 | 0.69824437 |
| 73 | MAP3K10 | 0.69515810 |
| 74 | CDK12 | 0.68691260 |
| 75 | BMPR2 | 0.68588215 |
| 76 | MAP3K7 | 0.68369258 |
| 77 | SMG1 | 0.68032541 |
| 78 | MAPKAPK2 | 0.64562312 |
| 79 | MAPK4 | 0.64506639 |
| 80 | MAPK12 | 0.64351001 |
| 81 | PTK2B | 0.63495806 |
| 82 | EGFR | 0.63263436 |
| 83 | MAP3K2 | 0.63040179 |
| 84 | CDC42BPA | 0.62796453 |
| 85 | BMX | 0.62720553 |
| 86 | STK11 | 0.62597367 |
| 87 | DAPK2 | 0.61997770 |
| 88 | MAP3K5 | 0.61267420 |
| 89 | ICK | 0.59460637 |
| 90 | DYRK1B | 0.59372090 |
| 91 | STK4 | 0.59052962 |
| 92 | MAP3K13 | 0.58806681 |
| 93 | TNK2 | 0.57416676 |
| 94 | PRKCD | 0.56545379 |
| 95 | MAPK7 | 0.56143027 |
| 96 | CAMK1G | 0.55570963 |
| 97 | FLT3 | 0.54698356 |
| 98 | SIK2 | 0.53735716 |
| 99 | CHUK | 0.53324747 |
| 100 | KDR | 0.52189620 |
| 101 | EPHA3 | 0.51975793 |
| 102 | PRKCQ | 0.51752989 |
| 103 | CDK7 | 0.49606494 |
| 104 | ABL1 | 0.49406969 |
| 105 | STK38 | 0.48995175 |
| 106 | ERBB3 | 0.48899341 |
| 107 | SGK3 | 0.48813297 |
| 108 | SIK1 | 0.48413488 |
| 109 | MAP2K6 | 0.46019947 |
| 110 | MAP3K8 | 0.44445219 |
| 111 | MAP3K12 | 0.44297108 |
| 112 | KSR1 | 0.41654973 |
| 113 | EEF2K | 0.41498329 |
| 114 | RET | 0.41070053 |
| 115 | FGFR3 | 0.40523774 |
| 116 | MAPK11 | 0.40469476 |
| 117 | FGFR4 | 0.40148904 |
| 118 | PRKG2 | 0.39615880 |
| 119 | RAF1 | 0.38914523 |
| 120 | PRKCZ | 0.36349185 |
| 121 | ALK | 0.36045357 |
| 122 | SCYL2 | 0.35870697 |
| 123 | CAMKK1 | 0.35259061 |
| 124 | CAMKK2 | 0.34980231 |
| 125 | NLK | 0.34502180 |
| 126 | FYN | 0.34405368 |
| 127 | PDK1 | 0.34246990 |
| 128 | RPS6KA2 | 0.33328741 |
| 129 | NME2 | 0.31672850 |
| 130 | PIK3CG | 0.29703720 |
| 131 | TAOK1 | 0.29145330 |
| 132 | TAOK2 | 0.28819478 |
| 133 | RPS6KA1 | 0.28380601 |
| 134 | NEK2 | 0.28196532 |
| 135 | PDPK1 | 0.26560656 |
| 136 | PRKCH | 0.26326550 |
| 137 | CDK4 | 0.26317663 |
| 138 | HIPK2 | 0.25826942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.40030877 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53248485 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.23397038 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02500259 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64514424 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.53953209 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35450814 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.30569870 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.20405687 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.17354528 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15814090 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07136243 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.04774593 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.88433114 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75482692 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73852272 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67191627 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.65395704 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62605993 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60918301 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.58277500 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57583319 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.53955186 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52903367 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.51885152 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49749454 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46493235 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44743320 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44193839 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42237128 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42143380 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33992208 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33252555 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.25316925 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24148868 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23517460 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.22793060 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22004034 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20443322 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.18480163 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17836025 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17517144 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.13407176 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12875170 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11955138 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09835791 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08969811 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06229061 |
| 49 | Asthma_Homo sapiens_hsa05310 | 1.05962623 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05332315 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 1.04447599 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01792172 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 1.01301131 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00791826 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00005406 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97115386 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90801254 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88031253 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85157964 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82883039 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80535612 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79012743 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77852731 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77803670 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.75404572 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71072994 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69697047 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.69047136 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68272365 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67652580 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67379188 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66916004 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65797747 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.64536116 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64384980 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63862340 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.62968058 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62167013 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62067528 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62062626 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61379334 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58587931 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57625918 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57615265 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57025619 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56804223 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56230610 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55982046 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55786684 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53132212 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53013065 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51326986 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51151803 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48259301 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48013972 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47616085 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47236555 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45479644 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45404325 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44632733 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.43370294 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42938726 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42170129 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41975027 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40035304 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.38669646 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37941408 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.36875331 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35173453 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.34246923 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33852822 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33034106 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31474252 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30298319 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29913791 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29021493 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.29019260 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28641400 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27991601 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.27609295 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27183270 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26719489 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24274706 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.24244145 |

